Wolters Kluwer to Divest ComplyTrack
September 08 2020 - 2:00PM
Wolters Kluwer to Divest
ComplyTrack
September 8, 2020 – Wolters
Kluwer Legal & Regulatory announces that it
has reached a binding agreement to sell ComplyTrack, a healthcare
regulatory risk and compliance solution, to
symplr, a provider of cloud-based
solutions for hospitals and other health
facilities.
“Wolters Kluwer Legal & Regulatory U.S. has an ongoing
strategy to focus on our digital information solutions and software
tools for law firms, corporate law departments, and related
compliance departments,” said Dean Sonderegger, Senior Vice
President and General Manager, Wolters Kluwer Legal &
Regulatory U.S. “In that light, the ComplyTrack product line has
limited strategic fit or synergies and this divestment will help us
to further advance our strategy.”
Rick Pleczko, President & CEO of symplr said, “The team and
I are looking forward to bringing ComplyTrack into our
portfolio—combining ComplyTrack’s modular solution with our
provider quality and patient safety SaaS platform creates a unique
offering for our customers and the market.”
The ComplyTrack business has about 50 full-time employees. The
transaction is expected to close before the end of the year.
About Wolters KluwerWolters
Kluwer (WKL) is a global leader in professional information,
software solutions, and services for the healthcare; tax and
accounting; governance, risk and compliance; and legal and
regulatory sectors. We help our customers make critical decisions
every day by providing expert solutions that combine deep domain
knowledge with specialized technology and services. Wolters Kluwer
reported 2019 annual revenues of €4.6 billion. The group serves
customers in over 180 countries, maintains operations in over 40
countries, and employs approximately 19,000 people worldwide. The
company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and
are included in the AEX and Euronext 100 indices. Wolters Kluwer
has a sponsored Level 1 American Depositary Receipt (ADR) program.
The ADRs are traded on the over-the-counter market in the U.S.
(WTKWY).
For more information, visit www.wolterskluwer.com, follow us on
Twitter, Facebook, LinkedIn, and YouTube.
Media
Investors/AnalystsGerbert van Genderen Stort
Meg GeldensCorporate
Communications
Investor Relationst + 31 172 641 230
t + 31 172 641
407
g.van.genderen.stort@wolterskluwer.com
ir@wolterskluwer.com
Forward-looking Statements and Other Important Legal
InformationThis report contains forward-looking
statements. These statements may be identified by words such as
“expect”, “should”, “could”, “shall” and similar expressions.
Wolters Kluwer cautions that such forward-looking statements are
qualified by certain risks and uncertainties that could cause
actual results and events to differ materially from what is
contemplated by the forward-looking statements. Factors which could
cause actual results to differ from these forward-looking
statements may include, without limitation, general economic
conditions; conditions in the markets in which Wolters Kluwer is
engaged; behavior of customers, suppliers, and competitors;
technological developments; the implementation and execution of new
ICT systems or outsourcing; and legal, tax, and regulatory rules
affecting Wolters Kluwer’s businesses, as well as risks related to
mergers, acquisitions, and divestments. In addition, financial
risks such as currency movements, interest rate fluctuations,
liquidity, and credit risks could influence future results. The
foregoing list of factors should not be construed as exhaustive.
Wolters Kluwer disclaims any intention or obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
- 2020.09.08 Wolters Kluwer to Divest ComplyTrack
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
From Apr 2023 to Apr 2024